Realistic AI voices for narration and dubbing.
View detailsRespeecher
Converts speech into another voice while keeping the original performance.
Respeecher is a voice cloning platform used in film, television, and games to recreate voices. It can de-age an actor's voice, recreate a voice from old recordings, or let one performer speak in another person's voice with remarkable accuracy.
Key Features
- High-fidelity voice cloning
- Voice de-aging for film and TV
- Speech-to-speech conversion
- Emotion and accent preservation
- Used in major productions
- Consent-based voice recreation
Pricing
| Plan | Price | Details |
|---|---|---|
| Pricing | Check official site | See the official site for current plans. |
Prices as listed in 2026 research. Always check the official site for the latest price — plans change. Free plan: No free plan — paid plans only.
Popular with: Video Creators, Developers, Business Owners
How it works
The technology is known for its work in major productions, where it has recreated voices for characters when the original actor could not record. Its models capture the nuances of a voice, including emotion and accent.
Respeecher is a professional service with custom pricing, aimed at studios and productions rather than casual creators. It works with consent and legal clearance for every voice it recreates.
Pros and Cons
✓ Pros
- Industry-leading cloning quality
- Trusted by major productions
- Captures emotion and nuance
- Consent and legal clearance built in
✗ Cons
- Custom pricing, expensive for individuals
- Project-based, not self-serve
- Requires voice rights and consent
Frequently Asked Questions
Is Respeecher free?
No — Respeecher has no free plan. Check official site
What is Respeecher best for?
film, TV, and game studios that need accurate voice cloning and de-aging.
What kind of tool is Respeecher?
Respeecher is a Voice & Audio tool on VerlumoAI.
Related Tools
Turn text into studio-quality voiceovers fast.
View detailsAI reading app that turns articles, PDFs, and books into natural audio.
View detailsLast reviewed: November 2026